These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 24067430

  • 1. Toward a working definition of C3 glomerulopathy by immunofluorescence.
    Hou J, Markowitz GS, Bomback AS, Appel GB, Herlitz LC, Barry Stokes M, D'Agati VD.
    Kidney Int; 2014 Feb; 85(2):450-6. PubMed ID: 24067430
    [Abstract] [Full Text] [Related]

  • 2. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
    Viswanathan GK, Nada R, Kumar A, Ramachandran R, Rayat CS, Jha V, Sakhuja V, Joshi K.
    Diagn Pathol; 2015 Mar 17; 10():6. PubMed ID: 25889427
    [Abstract] [Full Text] [Related]

  • 3. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
    Okuda Y, Ishikura K, Hamada R, Harada R, Sakai T, Hamasaki Y, Hataya H, Fukuzawa R, Ogata K, Honda M.
    Nephrology (Carlton); 2015 Apr 17; 20(4):286-92. PubMed ID: 25524631
    [Abstract] [Full Text] [Related]

  • 4. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
    Davis BK, Cavallo T.
    Am J Pathol; 1976 Aug 17; 84(2):283-98. PubMed ID: 133617
    [Abstract] [Full Text] [Related]

  • 5. C4 Glomerulopathy: A Disease Entity Associated With C4d Deposition.
    Sethi S, Quint PS, O'Seaghdha CM, Fervenza FC, Bijol V, Dorman A, Dasari S, Smith RJ, Kurtin PJ, Rennke HG.
    Am J Kidney Dis; 2016 Jun 17; 67(6):949-53. PubMed ID: 26896898
    [Abstract] [Full Text] [Related]

  • 6. Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy.
    Kersnik Levart T, Ferluga D, Vizjak A, Mraz J, Kojc N.
    Diagn Pathol; 2016 Oct 07; 11(1):94. PubMed ID: 27717365
    [Abstract] [Full Text] [Related]

  • 7. Alternative pathway dysfunction in kidney disease: a case report and review of dense deposit disease and C3 glomerulopathy.
    Hawfield A, Iskandar SS, Smith RJ.
    Am J Kidney Dis; 2013 May 07; 61(5):828-31. PubMed ID: 23391537
    [Abstract] [Full Text] [Related]

  • 8. Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits.
    Larsen CP, Messias NC, Walker PD, Fidler ME, Cornell LD, Hernandez LH, Alexander MP, Sethi S, Nasr SH.
    Kidney Int; 2015 Oct 07; 88(4):867-73. PubMed ID: 26154922
    [Abstract] [Full Text] [Related]

  • 9. Immunofluorescence patterns in chronic membranoproliferative glomerulonephritis (MPGN).
    Belgiojoso GB, Tarantino A, Bazzi C, Colasanti G, Guerra L, Durante A.
    Clin Nephrol; 1976 Jul 07; 6(1):303-10. PubMed ID: 782750
    [Abstract] [Full Text] [Related]

  • 10. Utility of immunohistochemistry with C3d in C3 glomerulopathy.
    Snijders MLH, van de Wall-Neecke BJ, Hesselink DA, Becker JU, Clahsen-van Groningen MC.
    Mod Pathol; 2020 Mar 07; 33(3):431-439. PubMed ID: 31477814
    [Abstract] [Full Text] [Related]

  • 11. C3 glomerulopathy and current dilemmas.
    Ito N, Ohashi R, Nagata M.
    Clin Exp Nephrol; 2017 Aug 07; 21(4):541-551. PubMed ID: 27878657
    [Abstract] [Full Text] [Related]

  • 12. The role of complement in C3 glomerulopathy.
    Zipfel PF, Skerka C, Chen Q, Wiech T, Goodship T, Johnson S, Fremeaux-Bacchi V, Nester C, de Córdoba SR, Noris M, Pickering M, Smith R.
    Mol Immunol; 2015 Sep 07; 67(1):21-30. PubMed ID: 25929733
    [Abstract] [Full Text] [Related]

  • 13. C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.
    Bomback AS, Santoriello D, Avasare RS, Regunathan-Shenk R, Canetta PA, Ahn W, Radhakrishnan J, Marasa M, Rosenstiel PE, Herlitz LC, Markowitz GS, D'Agati VD, Appel GB.
    Kidney Int; 2018 Apr 07; 93(4):977-985. PubMed ID: 29310824
    [Abstract] [Full Text] [Related]

  • 14. Histopathology of MPGN and C3 glomerulopathies.
    Cook HT, Pickering MC.
    Nat Rev Nephrol; 2015 Jan 07; 11(1):14-22. PubMed ID: 25447133
    [Abstract] [Full Text] [Related]

  • 15. Proliferative C4 Dense Deposit Disease, Acute Thrombotic Microangiopathy, a Monoclonal Gammopathy, and Acute Kidney Failure.
    Ali A, Schlanger L, Nasr SH, Sethi S, Gorbatkin SM.
    Am J Kidney Dis; 2016 Mar 07; 67(3):479-82. PubMed ID: 26704376
    [Abstract] [Full Text] [Related]

  • 16. C3 glomerulopathy: what's in a name?
    D'Agati VD, Bomback AS.
    Kidney Int; 2012 Aug 07; 82(4):379-81. PubMed ID: 22846813
    [Abstract] [Full Text] [Related]

  • 17. Morphologic variations of dense deposit disease: light and electron microscopic, immunohistochemical and clinical findings in 10 patients.
    Joh K, Aizawa S, Matsuyama N, Yamaguchi Y, Kitajima T, Sakai O, Mochizuki H, Usui N, Hamaguchi K, Mitarai T.
    Acta Pathol Jpn; 1993 Oct 07; 43(10):552-65. PubMed ID: 8291443
    [Abstract] [Full Text] [Related]

  • 18. Clinicopathological features of membranoproliferative glomerulonephritis under a new classification.
    Nargund P, Kambham N, Mehta K, Lafayette RA.
    Clin Nephrol; 2015 Dec 07; 84(6):323-30. PubMed ID: 26445002
    [Abstract] [Full Text] [Related]

  • 19. Immunofluorescence studies of dense deposit disease. The presence of railroad tracks and mesangial rings.
    Kim Y, Vernier RL, Fish AJ, Michael AF.
    Lab Invest; 1979 Apr 07; 40(4):474-80. PubMed ID: 372673
    [Abstract] [Full Text] [Related]

  • 20. C4d as a Diagnostic Tool in Proliferative GN.
    Sethi S, Nasr SH, De Vriese AS, Fervenza FC.
    J Am Soc Nephrol; 2015 Nov 07; 26(11):2852-9. PubMed ID: 25991041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.